Shares of Frequency Therapeutics (NASDAQ: FREQ) were crashing 74.9% as of 11:07 a.m. EDT on Tuesday. The huge drop came after the company announced disappointing top-line interim results from a phase 2a clinical study evaluating experimental therapy FX-322 in treating sensorineural hearing loss (SNHL).
Where can I buy Frequency Therapeutics (Freq) stock?
Mar 23, 2021 · Shares of Frequency Therapeutics (NASDAQ: FREQ) were crashing 74.9% as of 11:07 a.m. EDT on Tuesday. The huge drop came after the company announced disappointing top-line interim results from a ...
Where can I buy shares of Freq?
Apr 11, 2022 · finance.yahoo.com - December 7 at 6:40 AM. Frequency Therapeutics (NASDAQ:FREQ) investors are sitting on a loss of 81% if they invested a year ago. finance.yahoo.com - November 30 at 8:44 AM. Investors in Frequency Therapeutics (NASDAQ:FREQ) have unfortunately lost 73% over the last year.
When will Frequency Therapeutics'next quarterly earnings be out?
Mar 23, 2021 · Frequency Therapeutics's Stock Price And Volume Action Frequency Therapeutics's (NASDAQ:FREQ) stock has been falling Tuesday, down 72.55% to a price of $9.99. The stock's current volume for the ...
Is FREQ a good stock to buy?
When did FREQ go public?
What is frequency used for?
Is Frequency Therapeutics a buy right now?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Frequency Therapeutics in the last year. There are currently 1 ho...
How has Frequency Therapeutics' stock price been impacted by Coronavirus?
Frequency Therapeutics' stock was trading at $18.51 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Orga...
Are investors shorting Frequency Therapeutics?
Frequency Therapeutics saw a decline in short interest in February. As of February 28th, there was short interest totaling 1,090,000 shares, a decl...
When is Frequency Therapeutics' next earnings date?
Frequency Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, May 12th 2022. View our earnings forecast for...
How were Frequency Therapeutics' earnings last quarter?
Frequency Therapeutics, Inc. (NASDAQ:FREQ) released its earnings results on Tuesday, March, 15th. The company reported ($0.62) earnings per share (...
What price target have analysts set for FREQ?
3 brokerages have issued 1-year target prices for Frequency Therapeutics' shares. Their forecasts range from $9.00 to $20.00. On average, they expe...
Who are Frequency Therapeutics' key executives?
Frequency Therapeutics' management team includes the following people: Mr. David L. Lucchino , Co-Founder, Pres, CEO & Director (Age 52, Pay $1....
Who are some of Frequency Therapeutics' key competitors?
Some companies that are related to Frequency Therapeutics include Khosla Ventures Acquisition (KVSA) , Boston Therapeutics (BTHE) , Mersana Ther...
What other stocks do shareholders of Frequency Therapeutics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Frequency Therapeutics investors own include AbbVie (ABBV)...
Frequency Therapeutics's Stock Price And Volume Action
Frequency Therapeutics's (NASDAQ:FREQ) stock has been falling Tuesday, down 72.55% to a price of $9.99. The stock's current volume for the day is 4.93 million, which is approximately 1234.0% of its previous 30-day average volume of 399.22 thousand.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Frequency Therapeutics shares are trading lower after the company announced the interim FX-322 Phase 2a results showed that four weekly injections did not demonstrate improvements in hearing measures versus placebo.
Perspective On Recent Price Action
The stock's 50-day moving average was $43.36 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $58.37 and fallen to a low of $14.5.
How much of Frequency Therapeutics stock is owned by insiders?
14.70% of the stock of Frequency Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.
What is the ticker symbol for frequency therapeutics?
Frequency Therapeutics trades on the NASDAQ under the ticker symbol "FREQ."
How much does frequency therapeutics make?
How much money does Frequency Therapeutics make? Frequency Therapeutics has a market capitalization of $269.65 million and generates $36.98 million in revenue each year. The company earns $-26,510,000.00 in net income (profit) each year or ($0.82) on an earnings per share basis.
How many research reports have been made on frequency therapeutics?
Frequency Therapeutics has only been the subject of 1 research reports in the past 90 days.
What is frequency therapeutics?
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, Mass General Brigham, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. The company was incorporated in 2014 and is headquartered in Woburn, Massachusetts.
Does frequency therapeutics pay dividends?
Frequency Therapeutics does not currently pay a dividend.
What is the Vickers top buyer and seller report?
Daily – Vickers Top Buyers & Sellers for 01/05/2021 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Is Frequency Therapeutics a SNHL?
Frequency Therapeutics Inc (NASDAQ: FREQ) has announced that four additional sensorineural hearing loss (SNHL) subjects from its FX-322-111 open-label study achieved statistically significant hearing improvements. The patients were evaluated 8 to 12 months following initial dosing. Including the five initial responders, a total of nine subjects in the study (n=32) have shown statistically significant improvements in word recognition scores, a key measure of speech perception, at time points betw
